FDA approves first targeted therapy to treat a rare mutation in patients with gastrointestinal…
Ayvakit is a kinase inhibitor, meaning it blocks a type of enzyme called a kinase and helps keep the cancer cells from growing
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
therapy
FDA approves first targeted therapy to treat patients with painful complication of sickle cell…
Sickle cell disease is an inherited blood disorder in which the red blood cells are abnormally shaped which restricts the flow in…